Literature DB >> 24551301

Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.

Zhaojie Zhang1, Xiaolong Qi1, Zhiwei Li2, Lijun Xu1, Fei Wang1, Shenglan Wang1, Yizhong Chang1, Wanrong Ma1, Mingxin Xu1, Changqing Yang1.   

Abstract

OBJECTIVE: Hepatopulmonary syndrome (HPS) is considered as a triad of chronic liver disease, pulmonary vascular ectasia and severe hypoxemia. The study aims to investigate the pathological mechanism of intra-abdominal pressure (IAP) in HPS and establish a novel mouse model.
METHODS: Fifty male ICR mice were randomly divided into experimental and control group, receiving subcutaneous injection of carbon tetrachloride and water, respectively. Mice in experimental group were then divided into 4 sub-groups with the intraperitoneal injection of different volume of albumin to form different IAP (0, 5, 10 and 20 cmH2O). All the mice were then sacrificed 24 hours later and blood gas analysis was conducted. In addition, liver and lung histopathology was also examined.
RESULTS: Blood gas analysis in different IAP suggested the respiratory alkalosis. Arterial partial pressure of oxygen significantly decreased in the IAP=10 cmH2O (68.13 ± 3.56, P<0.01) and 20 cmH2O (66.00 ± 3.78, P<0.01). Alveolar-arterial oxygen pressure difference increased markedly in the IAP=10 cmH2O (54.60 ± 6.80, P<0.001) and 20 cmH2O (57.04 ± 5.60, P<0.001). According to lung histopathology, macrophages were found to accumulate in the alveolar spaces and the widened alveolar walls were detected. In addition, there was visible blood stasis in the alveolar walls and numerous red blood cells extravasated into air space in the IAP=10 and 20 cmH2O.
CONCLUSIONS: Our study suggested that intra-abdominal hypertension was a significant pathological mechanism of HPS. Meanwhile, we have established a novel mouse model that will now be optimized with further investigation of the mechanism and therapeutic targets of HPS.

Entities:  

Keywords:  Hepatopulmonary syndrome; abdominal compartment syndrome; animal model; intra-abdominal hypertension

Mesh:

Substances:

Year:  2014        PMID: 24551301      PMCID: PMC3925925     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  [Abdominal compartment syndrome].

Authors:  C G Schneider; J Scholz; J R Izbicki
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2000-08       Impact factor: 0.698

2.  A porcine model of the abdominal compartment syndrome.

Authors:  Christian Toens; Alexander Schachtrupp; Joerg Hoer; Karsten Junge; Bernd Klosterhalfen; Violker Schumpelick
Journal:  Shock       Date:  2002-10       Impact factor: 3.454

Review 3.  The abdominal compartment syndrome.

Authors:  R Reis; P Labas; M Vician; M Ziak
Journal:  Bratisl Lek Listy       Date:  2003       Impact factor: 1.278

Review 4.  Hepatopulmonary syndrome.

Authors:  Victor I Machicao; Michael B Fallon
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

5.  Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography.

Authors:  R Aller; J L Moya; V Moreira; D Boixeda; A Cano; J Picher; S García-Rull; D A de Luis
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis.

Authors:  Elspeth J Gold; Richard J B Francis; Arthur Zimmermann; Sally L Mellor; Mark Cranfield; Gail P Risbridger; Nigel P Groome; Antony M Wheatley; Jean S Fleming
Journal:  Mol Cell Endocrinol       Date:  2003-03-28       Impact factor: 4.102

7.  [Influence of intra-abdominal hypertension on the intestinal permeability and endotoxin/bacteria translocation in rabbits].

Authors:  Jun-tao Cheng; Guang-xia Xiao; Pei-yuan Xia; Jian-cheng Yuan; Xiao-jian Qin
Journal:  Zhonghua Shao Shang Za Zhi       Date:  2003-08

8.  Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats.

Authors:  S W Chang; N Ohara
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 9.  Pulmonary vascular disorders in portal hypertension.

Authors:  P Hervé; D Lebrec; F Brenot; G Simonneau; M Humbert; O Sitbon; P Duroux
Journal:  Eur Respir J       Date:  1998-05       Impact factor: 16.671

10.  Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.

Authors:  Anne Rabiller; Hilario Nunes; Didier Lebrec; Khalid A Tazi; Myriam Wartski; Elisabeth Dulmet; Jean-Marie Libert; Christine Mougeot; Richard Moreau; Michel Mazmanian; Marc Humbert; Philippe Hervé
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

View more
  1 in total

1.  Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury.

Authors:  Xin Zhao; Yanwu Jin; Haibo Li; Zhigang Wang; Wanlin Zhang; Chang Feng
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.